Trial Profile
A multi-centre, randomised, controlled, phase iii study to investigate the safety and efficacy of intravenous infusions of VIT-45 in patients with iron deficiency anaemia secondary to chronic inflammatory bowel disease
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Jun 2015
Price :
$35
*
At a glance
- Drugs Ferric carboxymaltose (Primary) ; Ferrous sulfate
- Indications Iron deficiency anaemia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Vifor
- 05 Jun 2015 New trial record